epirubicin

Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer
Viviana Murgia, Roberto Sorio, Claudia Griso, Orazio Caffo, Carmela Arcuri, Antonella Ferro, Alessia Caldara, Simona Scalone, Emilio Arisi, Enzo Galligioni

International Journal of Gynecologic Cancer Jul 2010, 20 (6) 953-957; DOI: 10.1111/IGC.0b013e3181e4a6c1
De novo uterine sarcoma with good response to neo-adjuvant chemotherapy
F. NUMA, K. UMAYAHARA, H. OGATA, S. NAWATA, Y. SAKAGUCHI, T. EMOTO, K. KAWASAKI, H. HIRAKAWA, M. SASE, A. OGA, H. KATO

International Journal of Gynecologic Cancer May 2003, 13 (3) 364-367; DOI: 10.1136/ijgc-00009577-200305000-00017
Efficacy and tolerability of the ifosfamide–epirubicin combination in relapsed ovarian cancer
F. Joly, H. Bourgeois, A. Floquet, P. Chinet-Charrot, F. Meyer, D. Lebrun, K. Hamond, C. Leroy, J. F. Heron

International Journal of Gynecologic Cancer Jan 2006, 16 (1) 77-82; DOI: 10.1136/ijgc-00009577-200601000-00013

Main menu